2019 annual financial data
Alnylam Pharmaceuticals 2019 Operating margin
Direct answer
Operating margin was -427.5%.
Operating income was -939,431,000 USD and net income was -886,116,000 USD.
Operating cash flow was -278,427,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 219,750,000 USD
- Operating income
- -939,431,000 USD
- Net income
- -886,116,000 USD
- Operating cash flow
- -278,427,000 USD